Predict your next investment

Corporation
HEALTHCARE | Biotechnology
vitaltherapies.com

See what CB Insights has to offer

Founded Year

2003

Stage

IPO | IPO

Total Raised

$189.24M

Date of IPO

4/17/2014

Market Cap

0.29B

Stock Price

9.39

About Vital Therapies

Vital Therapies is a development-stage biotechnology company developing ELAD, an extracorporeal liver support system which functions by processing toxins and synthesizing proteins and metabolites that are the key processes of normal human liver function, and represents the first human allogeneic cellular therapy for life-threatening acute liver failure. Vital Therapies has completed seven clinical trials in US, EU and Asia. A US/EU pivotal trial plan to secure BLA and MAA approval has received written guidance from FDA and EMA. The first protocol under this plan, for a survival trial in acute alcoholic hepatitis, has been allowed by FDA and is open for enrollment.

Vital Therapies Headquarter Location

15010 Avenue of Science Suite 200

San Diego, California, 92128,

United States

858-673-6840

Latest Vital Therapies News

Immunic Therapeutics and Vital Therapies complete transaction creating Nasdaq-listed company...

Aug 12, 2019

Fund+ fosters innovation by investing in Life Sciences Fund+ is an open-ended Fund for long term equity investment in innovative Life Sciences companies with a fo cus on Belgium. We want to create sustainable shareholders value, contribute to the development of a leadership position in the Life Sciences sector and generate a tangible, beneficial societal impact. test

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Vital Therapies Patents

Vital Therapies has filed 6 patents.

The 3 most popular patent topics include:

  • Hepatology
  • Autoimmune diseases
  • Cell biology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/20/2008

5/6/2014

G protein coupled receptors, Human cell lines, Transcription factors, Complement system, Immunology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

6/20/2008

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

5/6/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

G protein coupled receptors, Human cell lines, Transcription factors, Complement system, Immunology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Vital Therapies Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Vital Therapies Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.